Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840

Author: Wulff Heike  

Publisher: Informa Healthcare

ISSN: 1354-3776

Source: Expert Opinion on Therapeutic Patents, Vol.20, Iss.12, 2010-12, pp. : 1759-1765

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract